Oestrogen receptor-α polymorphism and risk of fracture: A meta-analysis of 13 studies including 1279 cases and 6069 controls

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1575-1583

  Lei, M M ^a   Yang, T F ^a   Tu, Z Q ^a   Liu, L ^a   Fang, Y ^a   Wang, G L ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Fracture; Gene polymorphism; Meta analysi; Oestrogen receptor

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ARTICLE; ETHNICITY; FRACTURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HIP FRACTURE; HORMONE RESPONSE; HUMAN; RISK ASSESSMENT; RISK FACTOR; VERTEBRA FRACTURE;

EID: 78449276562     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800502     Document Type: Article

References (43)

1. Gennari L, Merlotti D, De Paola V, et al: Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 2005; 161: 307-320.
2. Ji GR, Yao M, Sun CY, et al: Association of collagen type I α1 (COLIA1) Sp1 polymorphism with osteoporotic fracture in Caucasian post-menopausal women: a meta-analysis. J Int Med Res 2009; 37: 1725-1732.
3. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, et al: Estrogen receptor α polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case- control studies and a meta-analysis. Circulation 2007; 115: 861-871.
4. Wang CL, Tang XY, Chen WQ, et al: Association of estrogen receptor alpha gene polymorphisms with bone mineral density in Chinese women: a meta-analysis. Osteoporos Int 2007; 18: 295-305.
5. Ioannidis JP, Stavrou I, Trikalinos TA, et al: Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 2002; 17: 2048-2060.
6. Vandevyver C, Vanhoof J, Declerck K, et al: Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. J Bone Miner Res 1999; 14: 1576-1582.
7. Langdahl BL, Lokke E, Carstens M, et al: ATA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not. J Bone Miner Res 2000; 15: 2222-2230.
8. Becherini L, Gennari L, Masi L, et al: Evidence of alinkagedisequilibriumbetween polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 2000; 9: 2043-2050.
9. Aerssens J, Dequeker J, Peeters J, et al: Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women. Osteoporos Int 2000; 11: 583-591.
10. Salmén T, Heikkinen AM, Mahonen A, et al: The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor α genotype in early postmenopausal women. J Bone Miner Res 2000; 15: 2479-2486.
11. Albagha OM, McGuigan FE, Reid DM, et al: Estrogen receptor α gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res 2001; 16: 128-134.
12. Efstathiadou Z, Kranas V, Ioannidis JP, et al: The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int 2001; 12: 326-331.
13. Kobayashi N, Fujino T, Shirogane T, et al: Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 2002; 41: 193-201.
14. Colin EM, Uitterlinden AG, Meurs JB, et al: Interaction between vitamin D receptor genotype and estrogen receptor α genotype influences vertebral fracture risk. J Clin Endocrinol Metab 2003; 88: 3777-3784.
15. van Meurs JB, Schuit SC, Weel AE, et al: Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 2003; 12: 1745-1754.
16. Robins J, Greenland S, Breslow NE: A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986; 124: 719-723.
17. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
18. Egger M, Davey Smith G, Schneider M, et al: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
19. Duan Y, Tabensky A, DeLuca V, et al: The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur. Bone 1997; 21: 447-451.
20. Kurabayashi T, Tomita M, Matsushita H, et al: Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 1999; 180: 1115-1120.
21. Rivadeneira F, van Meurs JB, Kant J, et al: Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influencethe riskoffracturein postmenopausal women. J Bone Miner Res 2006; 21: 1443-1456.
22. Salmén T, Heikkinen AM, Mahonen A, et al: Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women. Ann Med 2002; 34: 64-72.
23. Mitra S, Desai M, Khatkhatay MI: Association of estrogen receptor α gene polymorphisms with bone mineral density in postmenopausal Indian women. Mol Genet Metab 2006; 87: 80-87.
24. Jakimiuk A, Nowicka M, Bogusiewicz M, et al: Prevalence of estrogen receptor α PvuII and XbaI polymorphism in population of Polish postmenopausal women. Folia Histochem Cytobiol 2007; 45: 331-338.
25. Lanyon L, Armstrong V, Ong D, et al: Is estrogen receptor α key to controlling bones' resistance to fracture? J Endocrinol 2004; 182: 183-191.
26. Weiderpass E, Persson I, Melhus H, et al: Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000; 21: 623-627.
27. Sobczuk A, Smolarz B, Romanowicz-Makowska H, et al: Estrogen receptor alpha (ER-alpha) gene polymorphism in patients from the Lodz region of Poland with sporadic endometrial cancer. Eur J Gynaecol Oncol 2009; 30: 431-434.
28. Wedrén S, Lovmar L, Humphreys K, et al: Estrogen receptor alpha gene polymorphism and endometrial cancer risk - a case-control study. BMC Cancer 2008; 8: 322.
29. Sasaki M, Tanaka Y, Kaneuchi M, et al: CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor α and estrogen receptor β expressions. Cancer Res 2003; 63: 3913-3918.
30. Iwamoto I, Fujino T, Douchi T, et al: Association of estrogen receptor alpha and beta3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol 2003; 102: 506-511.
31. Sasaki M, Tanaka Y, Kaneuchi M, et al: Polymorphisms of estrogen receptor α gene in endometrial cancer. Biochem Biophys Res Commun 2002; 297: 558-564.
32. Anghel A, Raica M, Narita D, et al: Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer. Neoplasma 2010; 57: 306-315.
33. Sobczuk A, Perty nski T, Smolarz B, et al: The analysis of estrogen receptor alpha (ER-alpha) gene Pvull and Xbal polymorphisms in postmenopausal women with breast cancer. Pol Merkur Lekarski 2008; 25: 43-45 [in Polish, English abstract].
34. Modugno F, Zmuda JM, Potter D, et al: Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian women. Int J Cancer 2005; 116: 984-991.
35. Shin A, Kang D, Nishio H, et al: Estrogen receptor alpha gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 2003; 80: 127-131.
36. Cai Q, Shu XO, Jin F, et al: Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003; 12: 853-859.
37. González-Zuloeta Ladd AM, Vásquez AA, Rivadeneira F, et al: Estrogen receptor α polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat 2008; 107: 415-419.
38. Gupta L, Thakur H, Sobti RC, et al: Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population. Mol Cell Biochem 2010; 335: 255-261.
39. Bergner CC, Krause FS, Zugor V, et al: Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC- EW and PC-OR cell lines. Anticancer Res 2007; 27: 2071-2074.
40. Hernández J, Balic I, Johnson-Pais TL, et al: Association between an estrogen receptor- gene polymorphism and the risk of prostate cancer in black men. J Urol 2006; 175: 523-527.
41. Tanaka Y, Sasaki M, Kaneuchi M, et al: Polymorphisms of estrogen receptor α in prostate cancer. Mol Carcinog 2003; 37: 202-208.
42. Cancel-Tassin G, Latil A, Rousseau F, et al: Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. Eur Urol 2003; 44: 487-490.
43. Little J, Higgins JP, Ioannidis JP, et al: Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009; 125: 131-151.